MedTrace Logo

Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)

NCT00263393 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3712

Last updated 2018-09-12

No results posted yet for this study

Summary

This study will evaluate the effectiveness of a novel cardiovascular disease prevention program designed for delivery through existing primary health care services in rural villages in Andhra Pradesh.

The primary aim is to increase the number of high-risk individuals in the population that are appropriately managed with proven, low-cost preventive interventions. The corresponding null hypothesis is therefore that the prevention program will result in no change in the proportion of high-risk individuals identified and treated in villages assigned to intervention compared with those villages assigned to control.

Conditions

Interventions

DRUG

ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin

The first intervention was a clinical algorithm designed to enhance the identification and treatment of high-risk individuals compared to continued usual care. The algorithm was designed to be used by either physician or non-physician health care workers.

BEHAVIORAL

Health Promotion

The second intervention was a health promotion program designed to increase knowledge of cardiovascular risk factors compared to continued usual practices.

Sponsors & Collaborators

  • Byrraju Foundation

    collaborator OTHER

  • The Future Forum, UK

    collaborator UNKNOWN

  • The George Institute

    lead OTHER

Principal Investigators

  • Bruce C Neal · The George Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2008-12-31
Completion
2009-06-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263393 on ClinicalTrials.gov